Literature DB >> 22775398

Chinese patients with Huntington's disease initially presenting with spinocerebellar ataxia.

Y Dong1, Y-M Sun, Z-J Liu, W Ni, S-S Shi, Z-Y Wu.   

Abstract

Recent studies have described Huntington's disease (HD) patients with atypical onset of ataxia. Symptoms in these patients can overlap with those of spinocerebellar ataxia (SCA). We retrospectively examined clinical data for 82 HD probands and found 7 had initially been clinically diagnosed as SCA cases. Clinical features in these patients were further investigated and the number of CAG repeats in the huntingtin (HTT) gene was determined by direct sequencing. Genetic screenings for SCAs in the 7 patients were all negative. By contrast, HTT was heterozygous in each patient. The distribution of CAG number in the 7 patients was statistically the same as that in the other 75 patients. Each of 7 HD patients had presented with atypical onset of ataxia. The mean time from onset to HTT genetic testing was 5.6 ± 5.52 years. Three of the patients developed chorea, but the others did not. Our observations confirm the clinical heterogeneity of HD in Han Chinese. Based on these findings, testing for HTT expansions should be considered for clinically diagnosed SCA patients who test negatively in genetic screening of SCA genes.
© 2012 John Wiley & Sons A/S. Published by Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22775398     DOI: 10.1111/j.1399-0004.2012.01927.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  11 in total

1.  Huntington's disease: lessons from prion disorders.

Authors:  Melanie Alpaugh; Francesca Cicchetti
Journal:  J Neurol       Date:  2021-02-24       Impact factor: 4.849

2.  Correlation Between CCG Polymorphisms and CAG Repeats During Germline Transmission in Chinese Patients with Huntington's Disease.

Authors:  Hong-Rong Cheng; Xiao-Yan Li; Hui-Li Yu; Miao Xu; Yan-Bin Zhang; Shi-Rui Gan; Hong-Lei Li; Zhi-Ying Wu
Journal:  Neurosci Bull       Date:  2020-03-19       Impact factor: 5.203

3.  Huntington's disease masquerading as spinocerebellar ataxia.

Authors:  Sergio Alejandro Rodríguez-Quiroga; Dolores Gonzalez-Morón; Nelida Garretto; Marcelo Andres Kauffman
Journal:  BMJ Case Rep       Date:  2013-07-12

Review 4.  Development of Research on Huntington Disease in China.

Authors:  Hong-Lei Li; Yan-Bin Zhang; Zhi-Ying Wu
Journal:  Neurosci Bull       Date:  2016-12-28       Impact factor: 5.203

5.  Acanthocytes Identified in Huntington's Disease.

Authors:  Yueyi Yu; Yuanyuan Lu; Fen Wang; Yan Lu; Beijia Xie; Xiaosheng Meng; Yi Tang
Journal:  Front Neurosci       Date:  2022-06-06       Impact factor: 5.152

Review 6.  Huntington's Disease: Relationship Between Phenotype and Genotype.

Authors:  Yi-Min Sun; Yan-Bin Zhang; Zhi-Ying Wu
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

7.  Computational neurobiology is a useful tool in translational neurology: the example of ataxia.

Authors:  Sherry-Ann Brown; Louise D McCullough; Leslie M Loew
Journal:  Front Neurosci       Date:  2015-01-21       Impact factor: 4.677

Review 8.  Huntington Disease in Asia.

Authors:  Miao Xu; Zhi-Ying Wu
Journal:  Chin Med J (Engl)       Date:  2015-07-05       Impact factor: 2.628

9.  Clinical and Genetic Profiles in Chinese Patients with Huntington's Disease: A Ten-year Multicenter Study in China.

Authors:  Hong-Lei Li; Xiao-Yan Li; Yi Dong; Yan-Bin Zhang; Hong-Rong Cheng; Shi-Rui Gan; Zhi-Jun Liu; Wang Ni; Jean-Marc Burgunder; X William Yang; Zhi-Ying Wu
Journal:  Aging Dis       Date:  2019-10-01       Impact factor: 6.745

10.  A Targeted Gene Panel That Covers Coding, Non-coding and Short Tandem Repeat Regions Improves the Diagnosis of Patients With Neurodegenerative Diseases.

Authors:  Allen Chi-Shing Yu; Aldrin Kay-Yuen Yim; Anne Yin-Yan Chan; Liz Y P Yuen; Wing Chi Au; Timothy H T Cheng; Xiao Lin; Jing-Woei Li; Larry W L Chan; Vincent C T Mok; Ting-Fung Chan; Ho Yin Edwin Chan
Journal:  Front Neurosci       Date:  2019-12-11       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.